Braidwell’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.6M Hold
2,578,404
1.32% 27
2025
Q1
$41.6M Hold
2,578,404
1.46% 30
2024
Q4
$60M Buy
2,578,404
+388,568
+18% +$9.05M 1.78% 21
2024
Q3
$64.4M Sell
2,189,836
-324,702
-13% -$9.55M 1.83% 23
2024
Q2
$59.1M Buy
2,514,538
+1,999,538
+388% +$47M 1.85% 20
2024
Q1
$19.5M Hold
515,000
0.63% 51
2023
Q4
$11.1M Buy
+515,000
New +$11.1M 0.41% 56